Discover
CRBU
Caribou Biosciences, Inc.
1.76
3 x 1.70
2 x 2.21
bid
ask
+
0.00
0.00%
3 @ 04:08 AM
1.74 -0.02 (1.29%)
| Ytd | 10.69% | |
| 1y | 40.80% |
1.73
day range
1.78
1.24
52 week range
3.54
| Open | 1.76 | Prev Close | 1.76 | Low | 1.73 | High | 1.78 | Mkt Cap | 174.56M |
| Vol | 1.69M | Avg Vol | 1.90M | EPS | -1.42 | P/E | N/A | Forward P/E | -0.90 |
| Beta | 2.26 | Short Ratio | 4.55 | Inst. Own | 62.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.96 | 200-d Avg | 1.93 | 1yr Est | 12.50 |
CRBU News
globenewswire.com
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
BERKELEY, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a lead
benzinga.com
Caribou Biosciences Reports Longer Follow Up Data For Ongoing CaMMouflage Phase 1 Trial Of CB-011, O
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients